221 related articles for article (PubMed ID: 25248837)
1. Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.
Wu KC; Lu YH; Peng YH; Tsai TF; Kao YH; Yang HT; Lin CJ
J Cereb Blood Flow Metab; 2015 Jan; 35(1):37-47. PubMed ID: 25248837
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
3. Biochemical evaluation of the neurotoxicity of MPTP and MPP⁺ in embryonic and newborn mice.
Sai T; Uchida K; Nakayama H
J Toxicol Sci; 2013; 38(3):445-58. PubMed ID: 23665943
[TBL] [Abstract][Full Text] [Related]
4. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
König J; Zolk O; Singer K; Hoffmann C; Fromm MF
Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
[TBL] [Abstract][Full Text] [Related]
5. Characterization of human organic cation transporter 1 (OCT1/SLC22A1)- and OCT2 (SLC22A2)-mediated transport of 1-(2-methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)- 4,9-dihydro-1H-naphtho[2,3-d]imidazolium bromide (YM155 monobromide), a novel small molecule survivin suppressant.
Minematsu T; Iwai M; Umehara K; Usui T; Kamimura H
Drug Metab Dispos; 2010 Jan; 38(1):1-4. PubMed ID: 19833842
[TBL] [Abstract][Full Text] [Related]
6. Acute Restraint Stress Augments 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Neurotoxicity via Increased Toxin Uptake into the Brain in C57BL/6 Mice.
Mitsumoto Y; Mori A
Neurosci Bull; 2018 Oct; 34(5):849-853. PubMed ID: 29987518
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants of organic cation transporter 1 (OCT1) and OCT2 significantly reduce lamivudine uptake.
Choi MK; Song IS
Biopharm Drug Dispos; 2012 Apr; 33(3):170-8. PubMed ID: 22415520
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin-induced renal injury is independently mediated by OCT2 and p53.
Sprowl JA; Lancaster CS; Pabla N; Hermann E; Kosloske AM; Gibson AA; Li L; Zeeh D; Schlatter E; Janke LJ; Ciarimboli G; Sparreboom A
Clin Cancer Res; 2014 Aug; 20(15):4026-35. PubMed ID: 24916697
[TBL] [Abstract][Full Text] [Related]
9. Extraneuronal monoamine transporter and organic cation transporters 1 and 2: a review of transport efficiency.
Schömig E; Lazar A; Gründemann D
Handb Exp Pharmacol; 2006; (175):151-80. PubMed ID: 16722235
[TBL] [Abstract][Full Text] [Related]
10. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression.
Hung HC; Lee EH
Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930
[TBL] [Abstract][Full Text] [Related]
11. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
[TBL] [Abstract][Full Text] [Related]
12. The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration.
Drouin-Ouellet J; Gibrat C; Bousquet M; Calon F; Kriz J; Cicchetti F
J Neuroinflammation; 2011 Oct; 8():137. PubMed ID: 21989292
[TBL] [Abstract][Full Text] [Related]
13. Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells.
Liou HH; Hsu HJ; Tsai YF; Shih CY; Chang YC; Lin CJ
Life Sci; 2007 Aug; 81(8):664-72. PubMed ID: 17689566
[TBL] [Abstract][Full Text] [Related]
14. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B).
Ito T; Suzuki K; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308
[TBL] [Abstract][Full Text] [Related]
15. In vitro interaction of clopidogrel and its hydrolysate with OCT1, OCT2 and OAT1.
Li L; Song F; Tu M; Wang K; Zhao L; Wu X; Zhou H; Xia Z; Jiang H
Int J Pharm; 2014 Apr; 465(1-2):5-10. PubMed ID: 24530383
[TBL] [Abstract][Full Text] [Related]
16. Calpain upregulation in spinal cords of mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson's disease.
Ray SK; Wilford GG; Ali SF; Banik NL
Ann N Y Acad Sci; 2000 Sep; 914():275-83. PubMed ID: 11085327
[TBL] [Abstract][Full Text] [Related]
17. Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.
Fillebeen C; Mitchell V; Dexter D; Benaissa M; Beauvillain J; Spik G; Pierce A
Brain Res Mol Brain Res; 1999 Oct; 72(2):183-94. PubMed ID: 10529477
[TBL] [Abstract][Full Text] [Related]
18. Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum.
Kawasaki T; Ishihara K; Ago Y; Baba A; Matsuda T
J Pharmacol Exp Ther; 2007 Jul; 322(1):274-81. PubMed ID: 17429058
[TBL] [Abstract][Full Text] [Related]
19. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
[TBL] [Abstract][Full Text] [Related]
20. MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Viaggi C; Vaglini F; Pardini C; Caramelli A; Corsini GU
Neuropharmacology; 2009 Jun; 56(8):1075-81. PubMed ID: 19298832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
